Hemodynamic effects of amrinone in children after fontan surgery

Anesthesia and Analgesia

Volumn 82, Issue 2, 1996, Pages 241-246

  Sorensen, Gregory K ^a,b   Ramamoorthy, Chandra ^a   Lynn, Anne M ^a   French, James ^a   Geoffrey Stevenson, J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DRUG CLEARANCE; DRUG EFFECT; FONTAN PROCEDURE; HEART OUTPUT; HEMODYNAMICS; HUMAN; LUNG VASCULAR RESISTANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AMRINONE; CARDIAC OUTPUT; CARDIOTONIC AGENTS; CHILD; CHILD, PRESCHOOL; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HEMODYNAMIC PROCESSES; HUMANS; INFANT; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; PULMONARY CIRCULATION; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 0030058044     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199602000-00004     Document Type: Article

References (15)

1. Robinson RJS, Tchervenkov C. Treatment of low cardiac output after aortocoronary artery bypass surgery using a combination of norepinephrine and amrinone. J Cardiothorac Anesth 1987;1:229-33.
2. Hines R. Clinical applications of amrinone. J Cardiothorac Anesth 1989;3:24-32.
3. Lawless S, Burckart G, Diven W, et al. Amrinone in neonates and infants after cardiac surgery. Crit Care Med 1989;17:751-4.
4. Robinson BW, Gelband H, Mas AS. Selective pulmonary and systemic vasodilator effects of amrinone in children: new therapeutic implications. J Am Coll Cardiol 1993;21:1461-5.
5. Lynn AM, Sorensen GK, Williams GW, et al. Hemodynarnic effects of amrinone and colloid administration in children following cardiac surgery. J Cardiothorac Anesth 1993;7:560-5.
6. Choussat A, Fontan F, Besse P, et al. Selection criteria for Fontan's procedure. In: Anderson RH, Shinebourne EA, eds. Paediatric cardiology. Edinburgh: Churchill Livingstone, 1978;559-66.
7. Hosking MP, Beynen FM. Modified Fontan procedure: physiology and anesthetic implications. J Cardiothorac Anesth 1992;6:465-75.
8. Deleon SY, Ilbawi MN, Idriss FS, et al. Persistent low cardiac output after the Fontan operation: should takedown be considered? J Thorac Cardiovasc Surg 1986;92:402-5.
9. Levy JH, Bailey JM. Amrinone: its effects on vascular resistance and capacitance in human subjects. Chest 1994;105:62-4.
10. Levy JH, Ramsay J, Bailey JM. Pharmacokinetics and pharmacodynamics of phosphodiesterase III inhibitors. J Cardiothorac Anesth 1990;4(Suppl 5):7-11.
11. Honerjager, P. Pharmacology of bipyridine phosphodiesterase III inhibitors. Am Heart J 1991;121(6 Pt 2):1939-44.
12. Reuter H. Localization of beta adrenergic receptors, and effects of noradrenaline and cyclic nucleotides on action potentials, ionic currents and tension in mammalian cardiac muscle. J Physiol 1974;242:429-51.
13. Thys DT. Cardiac output. Anes Clin North Am 1988;6:803-24.
14. Goldberg SJ, Allen HD, Marx GR, Donnerstein RL. Doppler echocardiography. Philadelphia: Lea & Febiger, 1988:165-7.
15. Edelson J, LeJemtel TH, Alousi AA. Relationship between amrinone plasma concentration and cardiac index. Clin Pharmacol Ther 1981;29:723-8.